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Effect of pH on the stability of methacholine 
chloride in solution 
B. L. WATSON, R. A. CORMIER AND R. J. HARBECK 
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, 
Denver, CO 80206, U.S.A. 
Methacholine chloride bronchoprovocation challenges are performed for the diagnosis and investigation of 
hyperreactive airways. Over the last 20 yrs various formulations and pH values for the preparation of solutions of 
methacholine have been described. To determine the stability of methacholine chloride solutions prepared in a 
variety of buffers with differing pH values and under varying storage temperatures, we measured methacholine 
concentrations at interyals from 1 to 5 weeks. It was found that methacholine chloride solutions rapidly decompose 
if the pH is greater than 6 and that decomposition is more rapid as the pH is raised; solutions at pH 9, i.e. 
bicarbonate buffer, and stored at 27°C have degradation up to 36% after only one week. Solutions of the same pH 
but prepared in different buffers can have both varied rates of deterioration and different absolute amounts of 
methacholine hydrolysed, e.g. solutions prepared in pH 9 borate buffer and stored at 27°C have up to 60% 
degradation after 1 week. Solutions prepared in saline are stable probably because methacholine solutions are 
weakly acidic. The results emphasise the importance of preparing methacholine chloride in the proper buffers for use 
in the accurate assessment of airway responsiveness. 
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Introduction 
Bronchoprovocation tests using methacholine chloride, a 
synthetic derivative of the neurotransmitter acetylcholine, is 
a valuable tool for the evaluation of non-specific airway 
responsiveness (l-5). To have reliable and reproducible 
results, it is imperative that the dosages and concentrations 
of methacholine be prepared accurately and be stable. 
Solutions from 0.03 mg ml - i to 25.0 mg ml ~ ’ are 
usually used in inhalation challenges. Since solutions of 
methacholine cannot be purchased commercially, dilutions 
must be prepared from crystals. Selection of the proper 
diluent is of paramount importance to the stability of 
solutions. Chai et al. (6) published information in which 
solutions were prepared from a diluent containing 0.5% 
sodium chloride, 0.275% sodium bicarbonate and 0.4% 
phenol; they stated that anything more dilute than 50 mg 
ml ~ ’ should be utilized within 7 days. MacDonald et al. (7) 
have published information in which a 5 mg ml - ’ solution 
was prepared using 0.9% sodium chloride. In such a solu- 
tion 10% degradation occurred at 20°C in two months and 
at 4°C in 5 months. These two reports, while seemingly 
contradictory, are explainable if the effect of pH on 
solutions is considered. 
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This present study was undertaken to determine the effect 
of pH on the stability of methacholine solutions at different 
pH values and different concentrations. The results 
obtained will inform physicians and investigators of the 
possible problems of using various diluents in the formation 
of methacholine solutions and will hopefully lead to the 
standardisation of methacholine chloride preparations. 
Methods 
MATERIALS AND REAGENTS 
Methacholine chloride (Spectrum Chemical Co., Gardena, 
CA; lot HK332) was stored at 4°C in its original sealed 
container until the time of use. The closed container was 
allowed to reach room temperature prior to weighing. This 
crystalline compound is hygroscopic (8,9); therefore, the 
weighing was done as quickly as possible to diminish any 
errors which could result from deliquescent crystals absorb- 
ing water. All other reagents and chemicals were American 
Chemical Society (ACS) or United States Pharmacopeia 
(USP) grade and used as obtained from commercial 
sources. 
ASSAY FOR METHACHOLINE 
The calorimetric procedure described by MacDonald 
et al. (7) was used to perform the quantitative analysis of 
methacholine solutions. This assay causes the conversion 
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of the ester moiety into a hydroxamic acid by reaction 
with hydroxylamine hydrochloride and sodium hydroxide. 
Ferric perchlorate is then added to form an amber- 
brown hydroxamic acid-iron complex which absorbs 
light at 530 nm. Solutions containing dibasic sodium 
phosphate form a precipitate after the addition of ferric 
perchlorate. This precipitate, if allowed to settle and 
the supernatant is assayed, did not affect the sensitivity 
or specificity of the test. The colored complex was 
measured between 18 and 22 h on a Beckman model DU-6 
spectrophotometer. 
In the first experiment (EXPl) seven separate buffers 
were prepared or purchased for the preparation of metha- 
choline solutions. The pH values of all buffers was deter- 
mined with a Beckman model 3500 digital pH meter and 
were found to be within f 0.1 of their intended pH. They 
are as follows: 
l pH 4, acetic acid and 0.02 M sodium acetate (10); 
l pH 5, citric acid and 0.03 M sodium citrate (11); 
l pH 6, citric acid and 0.06 M dibasic sodium phosphate 
(12); 
l pH 7. monobasic sodium phosphate and 0.06 M dibasic 
sodium phosphate (13); 
l pH 8, monobasic sodium phosphate and 0.09 M dibasic 
sodium phosphate (13); 
l pH 9, sodium bicarbonate and 0.05 M sodium carbonate 
(14); 
l pH 9 (B), boric acid-sodium hydroxide-potassium chlor- 
ide (Fisher Scientific, Pittsburgh, PA; SB114-500). 
Five dilutions of methacholine were chosen to be pre- 
pared with each buffer, i.e., 2.5, 5.0, 10.0, 12.5 and 20.0 mg 
ml-‘. Following the addition of the methacholine crystals 
the pH dropped in some of the buffers. Greater pH drops 
occurred when higher concentrations of methacholine 
crystals were added. Sodium hydroxide (1 M) was used to 
adjust the pH back to its intended pH (+ 0.1). Greater 
amounts of sodium hydroxide were added for higher 
methacholine concentrations than for lower concentrations. 
A five-point standard curve using these concentrations gave 
good linearity (r~0.9994). The coefficent of variation (CV) 
within samples also was good; 2.5 mg ml - ’ CVz3.6’~ 
(n=28), 5.0 mg ml - ’ CV=l.l% (n=28), lO.Omg ml-’ 
CV=O.9% (n=28), 12.5 mg ml- ’ CV= 1.4% (n=28) and 
20.0 mg ml - ’ CV=O.6% (n=28). These CVs were deter- 
mined by repeatedly assaying separate frozen aliquots 
over a period of 4 weeks and comparing the assayed 
values between each other. Concentrations greater than 
20,Omg ml-’ were not chosen to be tested because 
there was a deviation in linearity between the 20.0 mg ml - ’ 
and 25,Omg ml-’ points. Any concentration from 
25.0 mg ml - ’ and higher had 0% transmittance on the 
spectrophotometer. Concentrations less than 2.5 mg ml ~ ’ 
(1 .O, 0.5 and 0.25 mg ml - ‘) were attempted but were not 
selected because a CV of 5% or less was not obtainable; 
therefore, all points below 2.5 mg/ml were extrapolated 
based on the five higher points. This method sacrificed some 
accuracy for a greater gain in precision and was deemed 
appropriate because the curve remained linear below 
FIG. 1. The structure of methacholine chloride. 
2.5 mg ml- ’ when using the 1.0, 0.5 and 0.25 mg ml- ’ 
points. 
In a second experiment (EXP2), we used the same five 
concentrations of methacholine as in EXPl (2.5, 5.0, 10.0, 
12.5 and 20.0 mg ml - ‘), but the diluents used were saline 
and a solution containing 0.5% sodium chloride, 0.275% 
sodium bicarbonate and 0.4”/ phenol (pH 8.4). This buffer 
diluent maintained a constant pH ( f 0.1) after the addition 
of methacholine. We chose this buffer because many 
researchers, past and present, use it. The saline diluent 
became acidic with increasing amounts of methacholine 
(Fig. 1). No attempts were made to adjust pH back to its 
original pH because no such steps are taken in either 
research or clinical applications when these buffers are 
used. 
PROCEDURE AND SAMPLE ANALYSIS 
To determine the stability of solutions in EXPl, a baseline 
concentration was first needed. A baseline was determined 
by producing a standard curve using the previously 
described five points; all blanks were of the identical buffer 
used for the diluents and the measurements were performed 
in triplicate. Values were obtained for each of the five 
concentrations in all of the seven buffers by producing a 
least-squares linear regression curve from the five points 
and the concentrations of unknown samples were obtained 
from the standard plot. Every dilution was then separated 
into three aliquots. Each set of aliquots was stored in sterile 
12 mm x 75 mm polystyrene tubes and subjected to differ- 
ent temperatures. One set was placed in a temperature- 
controlled incubator (27 f 2”C), a second set was placed in 
a refrigerator (4 f 2°C) and the third set was placed in a 
freezer ( - 20 & 2°C). Frozen solutions retain their stability 
for up to 5 years (15); therefore, the - 20°C set contained 
the blanks and the reference standard solutions for use in 
subsequent assays. The calorimetric assay was performed 
weekly on every dilution (pH k-8), for a period of 3 weeks 
and up to 5 weeks for the bicarbonate buffer (pH 9) and 
the boric acid buffer [pH 9 (B)]. Samples were brought to 
room temperature and assayed in triplicate. The standard 
deviations were ~5% for all triplicate tests except for 
four dilutions (Table 1) which were ~10%. In short, each 
concentration was tested in triplicate at seven pH values 
(buffers) and at three temperatures. 
To determine the stability of solutions in EXP2 the same 
process was followed as in EXPI, except for the following 
variations: only the 4°C set of dilutions was compared with 
the frozen (standard curve) set; the calorimetric assay was 
performed every third week for 15 weeks, and the samples 
were assayed in duplicate. 
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TABLE 2. Percentage changes of methacholine concentrations, relative to initial concentration, prepared in saline or 
bicarbonate buffer containing 0.4% phenol 
Initial 
concentration 
Bicarbonate-phenol 
(mg ml ~ ‘) 3 weeks 6 weeks 9 weeks 12 weeks 15 weeks 
2.5 - 18.8 - 28.0 - 46.7 - 52.2 - 55.1 
5.0 - 13.5 - 24.5 - 35.6 - 45.1 -47.1 
10.0 - 7.2 - 19.2 - 21.5 - 27.5 - 27.8 
12.5 - 6.4 - 17.3 - 18.4 - 22.2 - 22.7 
20.0 - 4.0 - 12.4 - 16.0 - 17.7 - 15.4 
Saline 
3 weeks 6 weeks 9 weeks 12 weeks 15 weeks 
6.0 0.8 1.5 - 0.8 - 7.5 
3.7 0.2 2.0 0.8 - 2.4 
3.0 2.2 2.9 3.9 - 2.9 
1.3 1,6 - 0.4 2.0 - 0.8 
- 0.5 - 0.6 - 2.4 2.4 - 2.0 
Solutions were stored at 4°C * 2°C. 
Results 
Methacholine shows apparent degradation in solutions of 
pH 7 or greater (Table 1). At both 4°C and 27°C the rates of 
degradation are increased with increasing pH and at higher 
concentrations (absolute amount), although the percentage 
degradation is faster with lower concentrations (relative 
amount). At pH 9 there is 12% degradation after only 1 
week which increases to nearly 34% after 5 weeks when 
these solutions are stored at 4°C. Solutions at pH 9 and 
stored at 27°C have between 16% and 36% degradation 
after only 1 week. As expected, higher temperatures cause a 
faster rate of reaction. At pH values of 4, 5 and 6 no 
measurable amount of deterioration occurs at either 4°C or 
27°C. Solutions at pH 7 are relatively stable when stored at 
4°C; however, at 27°C degradation with time is more 
pronounced. 
Methacholine prepared in either pH 9 (bicarbonate 
buffer) or pH 9 (B) (boric acid buffer) showed different rates 
of deterioration. The methacholine prepared in the boric 
acid buffer had a faster initial degradation rate than did the 
methacholine prepared in the bicarbonate buffer, but the 
bicarbonate buffer caused a greater absolute loss of metha- 
choline (Table 1). This discrepancy is due to the fact that a 
boric acid buffer has a better buffering capacity than does a 
bicarbonate buffer of pH 9. Once the boric acid buffer 
exceeds its buffering capacity its pH drop is rapid, whereas 
the bicarbonate buffer has a gradual loss of pH over a 
longer period of time once its capacity is exceeded. 
Solutions prepared in bicarbonate-phenol buffer showed 
rapid deterioration over the test period of 15 weeks (Table 
2). Loss of methacholine increased as the timed points 
continued. Solutions prepared in saline showed no 
degradation during the same period (Table 2). 
Discussion 
The structure of methacholine (Fig. 1) is important in 
understanding its stability in solutions. Methacholine con- 
tains two functional portions, an ester group and a quater- 
nary ammonium cation. Esters undergo base-induced 
hydrolysis which cleaves the molecule into two products. 
In the case of methacholine, these products are 
p-methylcholine and acetate. The calorimetric assay is 
91 
8 
3 
3% 
0 5 10 15 20 25 30 
Concentration of methacholine chloride (mg ml?) 
FIG. 2. The pH of various concentrations of metha- 
choline prepared in either saline (0) or bicarbonate buffer 
containing 0.4% phenol (0). 
specific for the ester functional group and will not react 
with its byproducts. Hydrolysis is responsible for the 
degradation caused with higher pH. Methacholine can 
cause the indirect production of H+ by the action of its 
quaternary ammonium cation. The cation has the ability to 
solvate hydroxide ions formed by the self-ionisation of 
water, thereby producing hydronium ions which lower the 
pH of solutions. Some evidence suggests that solutions at 
pH values lower than 5 can slightly increase the airways 
responsiveness during an inhalation challenge (16). 
The discrepancy in reports between McDonald et al. (7) 
and Chai et al. (6) can now be explained. The diluent used 
by MacDonald was saline, and once methacholine was 
added the pH dropped (Fig. 2). Methacholine is stable in 
saline because the dilutions are pH 6 or less. Chai used a 
bicarbonate-phenol diluent (high pH). Using the simplified 
calculation, pH = 0,5(p&, + pK,,), and disregarding the 
acidic contribution of phenol (pK,= 10.00); a calculated pH 
of 8.3 was obtained for the bicarbonate-phenol diluent 
and the measured pH was 8.4. Methacholine rapidly 
decomposes (Table 2) in such a solvent because extensive 
hydrolysis occurs under these basic conditions. 
The present data deals with concentrations between 
2.5mg ml-’ and 20.0 mg ml- ‘. Methods have been 
devised to quantitate methacholine concentrations down to 
0.125 mg ml ~ ’ using a gas chromatograhic method (17), 
and down to 0.08 mg ml - ’ using a high-pressure liquid 
592 B. L. WATSON ET AL. 
chromatograhpic assay (18). A systematic study like that 
discussed in this study using either of these two techiques 
can be undertaken for measurement of solutions below 
2.5 mg ml - ’ and determine whether this pattern continues. 
If solutions are prepared in basic buffers and are assumed 
to be as stable as saline solvents, large amounts of metha- 
choline may decompose. Instances have occurred in which 
the methacholine bronchial provocation tests were normal 
on symptomatic patients (19). The hydrolysis of metha- 
choline in basic solutions could be one possible cause of this 
phenomenon. If methacholine solutions are prepared using 
basic buffers, rapid deterioration occurs. Inaccurate con- 
centrations could possibly result in missed diagnosis of 
asthma or the underdiagnosis of the severity of asthma. 
This point is apparently clear if the pattern of relative 
deterioration increases with decreasing concentrations. 
In conclusion, methacholine chloride solutions undergo 
hydrolysis if the pH exceeds 6. Solutions of higher pH will 
react faster owing to increased amounts of hydroxide ions 
(more basic), and the rates of reaction can vary between 
different basic buffers of like pH because their buffering 
capacities may vary. Solutions prepared in acidic buffers are 
more stable because the irreversible base-induced hydrolysis 
is not occurring. Saline solutions are weakly acidic which 
explains their relative stability. Phenol at 0.4% can be added 
to methacholine solutions stored for long periods of time to 
inhibit microbial growth. 
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